Compositions and methods for inhibiting expression of complement component 3 (C3)

TW202633668APending Publication Date: 2026-08-16SHANGHAI ARGO BIOPHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115101742
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-17
Filing Date
2026-01-16
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001073378_001
    Figure TWG2TA001073378_001
  • Figure TWG2TA001073378_002
    Figure TWG2TA001073378_002
  • Figure TWG2TA001073378_003
    Figure TWG2TA001073378_003
Patent Text Reader

Abstract

This invention provides compositions and methods for reducing C3 gene expression and for treating C3-related diseases and conditions. It provides C3 dsRNA agents, C3 antisense polynucleotide agents, compositions containing C3 dsRNA agents, and compositions containing C3 antisense polynucleotide agents that can be used to reduce C3 expression in cells and subjects.
Need to check novelty before this filing date? Find Prior Art